HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 169-180 of 7,264
Drug study icon
Not Yet RecruitingNCT07639099

Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression

Official study title

Impact of Intranasal Esketamine-dexmedetomidine Combination on Postpartum Depression in Parturients With Prenatal Depressive Symptoms: a Randomized, Double-blind, and Placebo-controlled Trial

This study isn't recruiting yet.

In Beijing
DepressionMedication studyAges 18+
Countries
China
Sponsor
Peking University First Hospital
Drug study icon
Not Yet RecruitingACTRN12625000329460

The INTENSIFY study: The Effect of a Six-Week Intensified Pharmacological Treatment (Third-Line Medication) for Major Depressive Disorder, Compared to Treatment as Usual (Second-Line Medication) in Participants Who Did Not Respond to a First-Line Medication Treatment.

Official study title

A Randomised, Controlled Trial to Investigate the Effect of a six-week Intensified Pharmacological Treatment for Major Depressive Disorder, compared to Treatment as Usual in Participants Who Had a First-time Treatment Failure on Their First-line Treatment for -Major Depressive Disorder Cohort.

This study isn't recruiting yet.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
Northern Adelaide Local Health Network
Drug study icon
RecruitingNCT07204314

Vortioxetine in Japanese Pediatric people with Major Depressive Disorder

Official study title

A Randomized, Double-blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once-Daily Oral Administration of Vortioxetine in Japanese Pediatric Patients 12 to 17 Years of Age With Major Depressive Disorder (MDD)

Multiple locations, including Nagoya
DepressionMedication studyAges 12–17
Countries
Japan
Sponsor
Takeda
Drug study icon
RecruitingNCT07196501

Maintenance Effect of Osavampator for depression

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)

Multiple locations, including Oceanside
DepressionMedication studyAges 18+
Countries
United States, Australia, Canada, + 8 others
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT06927076

Antidepressant Response of DMT Masked With Propofol

Official study title

Investigating the Role of the Psychedelic Experience in the Antidepressant Response in Patients With Major Depression: a Placebo-controlled Factorial Trial With DMT Masked With Propofol (DMT4D-Study)

In Basel
DepressionMedication studyAges 21+
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.